2005
Community Incidence of Hepatitis B and C among Reincarcerated Women
Macalino G, Vlahov D, Dickinson B, Schwartzapfel B, Rich J. Community Incidence of Hepatitis B and C among Reincarcerated Women. Clinical Infectious Diseases 2005, 41: 998-1002. PMID: 16142665, DOI: 10.1086/432936.Peer-Reviewed Original ResearchConceptsHepatitis B virusIncidence of HBVHCV infectionHepatitis BHepatitis C virus infectionC virus infectionDrug treatment servicesDrug-dependent personsIncident infectionsHIV testingBaseline prevalenceB virusCommunity incidenceIncidence rateVirus infectionTreatment servicesDrug useDrug dependenceInfectious diseasesInfectionSerum samplesIncidenceStudy periodWomenHCV
2003
Variability in the Incidence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection among Young Injecting Drug Users in New York City
Des Jarlais D, Diaz T, Perlis T, Vlahov D, Maslow C, Latka M, Rockwell R, Edwards V, Friedman S, Monterroso E, Williams I, Garfein R. Variability in the Incidence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection among Young Injecting Drug Users in New York City. American Journal Of Epidemiology 2003, 157: 467-471. PMID: 12615611, DOI: 10.1093/aje/kwf222.Peer-Reviewed Original ResearchConceptsHepatitis B virusHuman immunodeficiency virusHepatitis C virusImmunodeficiency virusB virusDrug usersHepatitis C virus infectionC virus infectionInjecting Drug UsersHigh HIV seroprevalenceHigh rateHBV incidenceHCV incidenceHCV transmissionCohort studyHIV seroprevalenceHIV incidenceHIV transmissionYoung Injecting Drug UsersC virusVirus infectionNew York CityIncidenceVirusYork City
2001
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City
Diaz T, Des Jarlais D, Vlahov D, Perlis T, Edwards V, Friedman S, Rockwell R, Hoover D, Williams I, Monterroso E. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. American Journal Of Public Health 2001, 91: 23-30. PMID: 11189819, PMCID: PMC1446499, DOI: 10.2105/ajph.91.1.23.Peer-Reviewed Original ResearchConceptsInjection drug usersYoung adult injection drug usersAdult injection drug usersHepatitis B virusDrug usersHCV infectionPrevalent hepatitis C virus infectionHepatitis C virus infectionYoung injection drug usersAnti-HCV positivityPrevalent HCV infectionPrevalent hepatitis CC virus infectionHIV serologyHCV antibodiesHepatitis CB virusVirus infectionDrug treatmentDrug useHCVNew York CitySex practicesInfectionUpper Manhattan
1996
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.
Garfein R, Vlahov D, Galai N, Doherty M, Nelson K. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal Of Public Health 1996, 86: 655-661. PMID: 8629715, PMCID: PMC1380472, DOI: 10.2105/ajph.86.5.655.Peer-Reviewed Original ResearchConceptsHepatitis B virusHepatitis C virusViral infectionSeroprevalence of HCVBlood-borne viral infectionsHuman T-lymphotropic virus type IShort-term injectorsHuman immunodeficiency virusSexual risk reduction interventionInjection drug usersIllicit drug injectorsRisk reduction interventionsVirus type IHepatitis CHepatitis BHIV infectionImmunodeficiency virusPrimary preventionC virusB virusHuman immunodeficiencyDrug injectionSequential cohortsDrug injectorsLymphotropic virusDifferences in the Incidence of Hepatitis B and Human Immunodeficiency Virus Infections among Injecting Drug Users
Levine O, Vlahov D, Brookmeyer R, Cohn S, Nelson K. Differences in the Incidence of Hepatitis B and Human Immunodeficiency Virus Infections among Injecting Drug Users. The Journal Of Infectious Diseases 1996, 173: 579-583. PMID: 8627020, DOI: 10.1093/infdis/173.3.579.Peer-Reviewed Original ResearchConceptsHepatitis B virusHBV seroconversionOutcome measuresDrug usersHuman immunodeficiency virus type 1 (HIV-1) seroconversionIncident hepatitis B virusHuman immunodeficiency virus (HIV) infectionHIV seroconversion ratesHIV-seronegative IDUsSubsequent HIV seroconversionImmunodeficiency virus infectionInjecting Drug UsersSurrogate outcome measureImportant outcome measureNeedle exchange programsMale IDUsHIV seroconversionIncident HIVSeroconversion ratesHepatitis BHIV infectionFemale IDUsB virusVirus infectionSeroconversion
1995
Seroepidemiology of Hepatitis B Virus in a Population of Injecting Drug Users
Levine O, Vlahov D, Koehler J, Cohn S, Spronk A, Nelson K. Seroepidemiology of Hepatitis B Virus in a Population of Injecting Drug Users. American Journal Of Epidemiology 1995, 142: 331-341. PMID: 7631637, DOI: 10.1093/oxfordjournals.aje.a117639.Peer-Reviewed Original ResearchConceptsDrug usersHBV seropositivityHBV seromarkersHepatitis B virus infectionDrug injecting equipmentHigh-risk sexual behaviorB virus infectionHuman immunodeficiency virusInjecting Drug UsersHepatitis B virusHepatitis C virusAfrican American ethnicityHBV transmissionParenteral transmissionHBV infectionImmunodeficiency virusInjecting equipmentSexual transmissionC virusB virusInjecting careerVirus infectionDrug useShooting galleriesStreet outreachOccupational risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections among funeral service practitioners in Maryland.
Gershon R, Vlahov D, Farzadegan H, Alter M. Occupational risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections among funeral service practitioners in Maryland. Infection Control And Hospital Epidemiology 1995, 16: 194-7. PMID: 7636165, DOI: 10.1086/647089.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHepatitis B virusHepatitis B vaccinationHepatitis C virusB vaccinationImmunodeficiency virusBloodborne pathogensB virusNon-occupational risk factorsHepatitis C virus infectionHepatitis B surface antigenHepatitis B surface antibodyBloodborne pathogen infectionsC virus infectionDoses of vaccineHepatitis B vaccineB surface antigenMarker of protectionB surface antibodyAdequate titersBloodborne exposuresHBV infectionHCV infectionB vaccineHIV infectionOccupational Risk of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infections Among Funeral Service Practitioners in Maryland
Gershon R, Vlahov D, Farzadegan H, Alter M. Occupational Risk of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infections Among Funeral Service Practitioners in Maryland. Infection Control And Hospital Epidemiology 1995, 16: 194-197. DOI: 10.2307/30140977.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHepatitis B virusHepatitis B vaccinationHepatitis C virusB vaccinationImmunodeficiency virusBloodborne pathogensB virusNon-occupational risk factorsHepatitis C virus infectionHepatitis B surface antigenHepatitis B surface antibodyBloodborne pathogen infectionsC virus infectionDoses of vaccineHepatitis B vaccineB surface antigenMarker of protectionB surface antibodyAdequate titersBloodborne exposuresHBV infectionHCV infectionB vaccineHIV infection